Keyphrases
First-trimester Screening
56%
Trisomy 21
56%
Pregnancy-associated Plasma protein-A (PAPP-A)
55%
Denmark
53%
First Trimester
47%
Trisomy 18
38%
Prenatal Screening
37%
Down Syndrome
35%
Pregnant Women
34%
Human Chorionic Gonadotropin
34%
Gestational Age
32%
Nuchal Translucency
29%
Pregnancy Trimester
29%
Congenital Heart Disease
29%
Trisomy 13
29%
Fetus
28%
Maternal Age
25%
Noninvasive Prenatal Testing
24%
Live Birth
22%
Screening for Trisomy 21
22%
Prenatal Diagnosis
21%
Multiple of the Median
21%
Small-for-gestational Age
21%
Screening Program
21%
Preeclampsia
20%
Repeated Sampling
19%
False-negative Case
19%
National Screening
19%
Fetal Medicine
17%
Neural Tube Defects
15%
High Risk
15%
Biochemistry, Genetics and Molecular Biology
First Trimester Pregnancy
100%
Pregnancy-Associated Plasma Protein A
54%
Human Chorionic Gonadotropin
50%
Trisomy 21
41%
Down Syndrome
38%
Prenatal Screening
29%
Maternal Age
25%
Aneuploidy
24%
Screening
20%
Small for Date Infant
19%
Trisomy
17%
Blood Protein
16%
Medicine and Dentistry
First Trimester Pregnancy
50%
Down Syndrome
38%
Screening
35%
Persistent Truncus Arteriosus
29%
Prenatal Screening
27%
Perinatology
24%
Gestational Age
21%
Prenatal Diagnosis
21%
Twin Pregnancy
19%
Pre-Eclampsia
19%
Trisomy 21
19%
Trisomy 18
19%
Trisomy 13
19%
Reproducibility
19%
Nuchal Translucency Measurement
18%
Obstetrics
16%
Second Trimester Pregnancy
15%
